United States Pharmaceuticals

Whitehawk Therapeutics Inc (WHWK)

Track

Over the last 90 days, Whitehawk Therapeutics Inc. has seen significant insider selling, with a net value of -$2.29 million. Executives were responsible for all of this net selling. Notably, the CFO and CEO have engaged in multiple sell transactions, including planned and proposed sales, totaling over $5 million in disclosed sales.
Stock chart
Ticker: WHWK Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Giacobello Scott M.
CHIEF FINANCIAL OFFICER
1 sale — total 584,808 USD
Sale 16 Apr 2026
Value US$3,593,636.49 | Price 497.16 | Shares 1,697
Planned sale 15 Apr 2026
Value US$1,267,280.02 | Price 140.15 | Shares 45,504
Proposed sale 15 Apr 2026
Value US$3,150,687.71 | Price 239.85 | Shares 51,822
Sale 14 Apr 2026
Value US$336,554.40 | Price 3.64 | Shares 92,460
Sale 13 Apr 2026
Value US$91,305.94 | Price 3.46 | Shares 26,389
Sale 10 Apr 2026
Value US$22,624.28 | Price 3.43 | Shares 6,596
Sale 9 Apr 2026
Value US$178,500.00 | Price 3.57 | Shares 50,000
Proposed sale 9 Apr 2026
Value US$649,997.70 | Price 3.30 | Shares 196,969
Sale 9 Apr 2026
Value US$49,010.00 | Price 3.38 | Shares 14,500
Proposed sale 9 Apr 2026
Value US$14,750.32 | Price 3.38 | Shares 4,364
Sale 8 Apr 2026
Value US$217,413.00 | Price 3.40 | Shares 63,945
Sale 7 Apr 2026
Value US$322,718.41 | Price 3.43 | Shares 94,087
Sale 6 Apr 2026
Value US$359,406.45 | Price 3.51 | Shares 102,395
Sale 2 Apr 2026
Value US$93,465.84 | Price 3.48 | Shares 26,858
Proposed sale 2 Apr 2026
Value US$1,034,398.68 | Price 3.48 | Shares 297,421
Sale 2 Mar 2026
Value US$16,878.96 | Price 3.31 | Shares 5,100
Sale 2 Mar 2026
Value US$8,585.10 | Price 3.31 | Shares 2,594
Sale 2 Mar 2026
Value US$6,069.81 | Price 3.31 | Shares 1,834
Sale 3 Mar 2025
Value US$5,045.45 | Price 2.35 | Shares 2,147
Proposed sale 3 Mar 2025
Value US$13,371.50 | Price 2.35 | Shares 5,690
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-17 2026-04-16 S Sale
2.7
Giacobello Scott M.

CHIEF FINANCIAL OFFICER

Officer
1,697 -7.5%
497.16
US$3,593,636 		1,697 -7.5% 497.16 US$3,593,636
2026-04-17 2026-04-15 PlS Planned sale
2.7
Giacobello Scott M.

CHIEF FINANCIAL OFFICER

Officer
45,504 -10.8%
140.15
US$1,267,280 		45,504 -10.8% 140.15 US$1,267,280
2026-04-15 2026-04-15 PrS Proposed sale
2.7
Giacobello Scott M.

Officer

Officer
51,822
239.85
US$3,150,688 		51,822 239.85 US$3,150,688
2026-04-15 2026-04-14 S Sale
2.6
BALL BRYAN

See remarks

Officer
92,460 -18.9%
3.64
US$336,554 		92,460 -18.9% 3.64 US$336,554
2026-04-15 2026-04-13 S Sale
2.6
BALL BRYAN

See remarks

Officer
26,389 -5.1%
3.46
US$91,306 		26,389 -5.1% 3.46 US$91,306
2026-04-13 2026-04-10 S Sale
2.6
BALL BRYAN

See remarks

Officer
6,596 -1.3%
3.43
US$22,624 		6,596 -1.3% 3.43 US$22,624
2026-04-13 2026-04-09 S Sale
2.6
BALL BRYAN

See remarks

Officer
50,000 -8.7%
3.57
US$178,500 		50,000 -8.7% 3.57 US$178,500
2026-04-10 2026-04-09 S Sale
1.6
Lennon David James

CHIEF EXECUTIVE OFFICER

Executive Director
14,500 -2.7%
3.38
US$49,010 		14,500 -2.7% 3.38 US$49,010
2026-04-09 2026-04-09 PrS Proposed sale
2.6
BALL BRYAN

Officer

Officer
196,969
3.30
US$649,998 		196,969 3.30 US$649,998
2026-04-09 2026-04-09 PrS Proposed sale
1.6
Lennon David James

Officer; Director

Executive Director
4,364
3.38
US$14,750 		4,364 3.38 US$14,750
2026-04-08 2026-04-08 S Sale
1.6
Lennon David James

CHIEF EXECUTIVE OFFICER

Executive Director
63,945 -10.7%
3.40
US$217,413 		63,945 -10.7% 3.40 US$217,413
2026-04-08 2026-04-07 S Sale
1.6
Lennon David James

CHIEF EXECUTIVE OFFICER

Executive Director
94,087 -13.6%
3.43
US$322,718 		94,087 -13.6% 3.43 US$322,718
2026-04-08 2026-04-06 S Sale
1.6
Lennon David James

CHIEF EXECUTIVE OFFICER

Executive Director
102,395 -12.9%
3.51
US$359,406 		102,395 -12.9% 3.51 US$359,406
2026-04-03 2026-04-02 S Sale
1.6
Lennon David James

CHIEF EXECUTIVE OFFICER

Executive Director
26,858 -3.3%
3.48
US$93,466 		26,858 -3.3% 3.48 US$93,466
2026-04-02 2026-04-02 PrS Proposed sale
1.6
Lennon David James

Officer; Director

Executive Director
297,421
3.48
US$1,034,399 		297,421 3.48 US$1,034,399
2026-03-10 2026-03-02 S Sale
1.6
Lennon David James

CHIEF EXECUTIVE OFFICER

Executive Director
5,100 -10.3%
3.31
US$16,879 		5,100 -10.3% 3.31 US$16,879
2026-03-10 2026-03-02 S Sale
2.7
Giacobello Scott M.

CHIEF FINANCIAL OFFICER

Officer
2,594 -8.5%
3.31
US$8,585 		2,594 -8.5% 3.31 US$8,585
2026-03-10 2026-03-02 S Sale
2.6
BALL BRYAN

See remarks

Officer
1,834 -0.9%
3.31
US$6,070 		1,834 -0.9% 3.31 US$6,070
2025-03-04 2025-03-03 S Sale
2.6
BALL BRYAN

See remarks

Officer
2,147 -2.0%
2.35
US$5,045 		2,147 -2.0% 2.35 US$5,045
2025-03-03 2025-03-03 PrS Proposed sale
1.6
Lennon David James

Officer; Director

Executive Director
5,690
2.35
US$13,372 		5,690 2.35 US$13,372
Explore more

More insider trading research around Whitehawk Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America